Effect of corticosteroids on wound healing after endoscopic sinus surgery

Rhinology

Volumn 47, Issue 3, 2009, Pages 280-286

  Jorissen, M ^a   Bechert, C ^b  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^b GHENT UNIVERSITY HOSPITAL   (Belgium)

Author keywords

Chronic rhinosinusitis; FESS; Mometasone furoate; Nasal polyps; Wound healing

Indexed keywords

ANTIINFLAMMATORY AGENT; MOMETASONE FUROATE; PREGNANE DERIVATIVE;

ADULT; ARTICLE; CHRONIC DISEASE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; ENDOSCOPY; FEMALE; HUMAN; MALE; MIDDLE AGED; NOSE POLYP; PILOT STUDY; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; RHINITIS; SINUSITIS; TOPICAL DRUG ADMINISTRATION; WOUND HEALING;

ADMINISTRATION, TOPICAL; ADULT; ANTI-INFLAMMATORY AGENTS; CHRONIC DISEASE; DOUBLE-BLIND METHOD; ENDOSCOPY; FEMALE; HUMANS; MALE; MIDDLE AGED; NASAL POLYPS; PILOT PROJECTS; PREGNADIENEDIOLS; PROSPECTIVE STUDIES; RHINITIS; SINUSITIS; WOUND HEALING; YOUNG ADULT;

EID: 70349675907     PISSN: 03000729     EISSN: None     Source Type: Journal    
DOI: 10.4193/Rhin08.227     Document Type: Article

References (32)

1. Aukema AAC, Fokkens WJ. Chronic rhinosinusitis: management for optimal outcomes. Treat Respire Med 2004; 3: 97-105.
2. Scadding GK, Durham SR, Mirakian R, et al. BSACI guidelines for the management of rhinosinusitis and nasal polyposis. Clin Exp Allergy 2008; 38: 260-275.
3. Fokkens W, Lund V, Mullol J, et al. European Position Paper on Rhinosinusitis and Nasal Polyps group. European position paper on rhinosinusitis and nasal polyps 2007. Rhinol Suppl 2007; 20 (Suppl 1): 1-136.
4. Hopkins C, Loh C, Roberts D. Medical versus surgical interventions for nasal polyps. (Protocol) Cochrane Database of Systematic Reviews 2008, Issue 1. Art. No.: CD006991.
5. Van Zele T, Claeys S, Gevaert P, et al. Differentiation of chronic sinus diseases by measurement of inflammatory mediators. Allergy 2006; 61:1280-1289.
6. Fokkens W, Lund V, Bachert C, et al. EAACI position paper on rhinosinusitis and nasal polyps executive summary. Allergy 2005; 60: 583-601. (Pubitemid 40562464)
7. Lazard DS, Prulière-Escabasse V, Papon JF, Escudier E, Coste A. Blessure et réparation épithé1iale: une hypothèse physiopathologique de la polypose nasosinusienne. Presse Med. 2007; 36:1104-1108.
8. Watelet JB, Demetter P, Claeys C, Van Cauwenberge P, Cuvelier C, Bachert C. Neutrophil-derived metalloproteinase-9 predicts healing quality after sinus surgery. Laryngoscope 2005; 115: 56-61.
9. Vining EM. Evolution of medical management of chronic rhinosinusitis. Ann Otol Rhinol Laryngol Suppl 2006; 196: 54-60.
10. Stammberger H. Surgical treatment of nasal polyps: past, present, and future. Allergy 1999; 54 (Suppl 53): 7-11.
11. Beule AG, Scharf C, Biebler KE, et al. Effects of topically applied dexamethasone on mucosal wound healing using a drug-releasing stent. Laryngoscope 2008; 118: 2073-2077.
12. Annys E, Jorissen M. Short term effects of antibiotics (Zinnat) after endoscopic sinus surgery. Acta Oto-rhino-laryngologica Belg 2000; 54: 23-28.
13. Jorissen M. Postoperative care following endoscopic sinus surgery. Rhinology 2004; 42; 114-120.
14. Virolainen E, Puhakka H. The effect of intranasal beclomethasone dipropionate on the recurrence of nasal polyps after ethmoidectomy. Rhinology 1980; 18: 9-18.
15. Dijkstra MD, Ebbens FA, Poublon RM, Fokkens WJ. Fluticasone propionate aqueous nasal spray does not influence the recurrence rate of chronic rhinosinusitis and nasal polyps 1 year after functional endoscopic sinus surgery. Clin Exp Allergy 2004; 34: 1395-1400.
16. Rowe-Jones JM, Medcalf M, Durham SR, Richards DH, Mackay IS. Functional endoscopic sinus surgery: 5 year follow up and results of a prospective, randomised, stratified, double-blind, placebo controlled study of postoperative fluticasone propionate aqueous nasal spray. Rhinology 2005; 43: 2-10.
17. Kanowitz SJ, Batra PS, Citardi MJ.Topical budesonide via mucosal atomization device in refractory postoperative chronic rhinosinusitis. Otolaryngol Head Neck Surg 2008; 139: 131-136.
18. Passàli D, Bernstein JM, Passali FM, Damiani V, Passàli GC, Bellussi L. Treatment of recurrent chronic hyperplastic sinusitis with nasal polyposis. Arch Otolaryngol Head Neck Surg 2003; 129: 656-659.
19. Stjärne P, Olsson P. Mometasone furoate prolongs post-FESS return of nasal polyps. Otolaryngol Head Neck Surg 2007; 137 (Suppl 1): P273 (abstract).
20. Lund VJ, Kennedy DW. Quantification for staging sinusitis. The Staging and Therapy Group. Ann Otol Rhinol Laryngol (Suppl) 1995; 167: 17-21.
21. Nadaraya, EA. On Estimating Regression. Theory of Probability and its Applications 1964; 9:141-142.
22. van Drunen C, Meltzer EO, Bachert C, Bousquet J, Fokkens WJ. Nasal allergies and beyond: a clinical review of the pharmacology, efficacy, and safety of mometasone furoate. Allergy 2005; 60 (Suppl 80): 5-19.
23. Meltzer EO, Charous BL, Busse WW, Zinreich SJ, Lorber RR, Danzig MR. Added relief in the treatment of acute recurrent sinusitis with adjunctive mometasone furoate nasal spray. The Nasonex Sinusitis Group. J Allergy Clin Immunol 2000; 106: 630-637.
24. Nayak AS, Settipane GA, Pedinoff A, et al. Effective dose range of mometasone furoate nasal spray in the treatment of acute rhinosinusitis. Ann Allergy Asthma Immunol 2002; 89: 271-278.
25. Meltzer EO, Bachert C, Staudinger H. Treating acute rhinosinusitis: comparing efficacy and safety of mometasone furoate nasal spray, amoxicillin, and placebo. J Allergy Clin Immunol 2005; 116: 1289-1295.
26. Bachert C, Meltzer EO. Effect of mometasone furoate nasal spray on quality of life of patients with acute rhinosinusitis. Rhinology 2007; 45: 190-196.
27. Small CB, Stryszak P, Danzig M, Damiano A. Onset of symptomatic effect of mometasone furoate nasal spray in the treatment of nasal polyposis. J Allergy Clin Immunol 2008; 121: 928-932.
28. Small CB, Hernandez J, Reyes A, et al. Efficacy and safety of mometasone furoate nasal spray in nasal polyposis. J Allergy Clin Immunol 2005; 116:1275-1281.
29. Stjarne P, Blomgren K, Cayé-Thomasen P, Salo S, Søderstrem T. The efficacy and safety of once-daily mometasone furoate nasal spray in nasal polyposis: a randomized, double-blind, placebo-controlled study. Acta Otolaryngol 2006; 126: 606-612.
30. Stjärne P, Mösges R, Jorissen M, Passàli D, Bellussi L, Staudinger H, Danzig M. A randomized controlled trial of mometasone furoate nasal spray for the treatment of nasal polyposis. Arch Otolaryngol Head Neck Surg 2006; 132: 179-185.
31. Zitt M, Kosoglou T, Hubbell J. Mometasone furoate nasal spray: a review of safety and systemic effects. Drug Saf 2007; 30: 317-326.
32. Minshall E, Ghaffar O, Cameron L, et al. Assessment by nasal biopsy of long-term use of mometasone furoate aqueous nasal spray (Nasonex) in the treatment of perennial rhinitis. Otolaryngol Head Neck Surg 1998; 118: 648-654.